Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Market
CNS diseases
Location
New York,
New York,
United States
Coinvestors
180 Degree Capital, AbbVie Biotech Ventures, Alexandria Real Estate Equities, ARCH Venture Partners, Eli Lilly and Company, Innovate NY Fund, Johnson & Johnson Development Corporation (JJDC), Partnership Fund for New York City, Pfizer Strategic Investments Group, Watson Fund, WuXi Corporate Venture Fund